Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Establishment Labs Holdings
ESTA
Establishment Labs Holdings
Surgeon Adoption And Patient Demand Will Expand Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
28 May 25
Updated
15 Aug 25
1
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$54.88
20.5% undervalued
intrinsic discount
15 Aug
US$43.64
Loading
1Y
-4.4%
7D
13.9%
Author's Valuation
US$54.9
20.5% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$54.9
20.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-89m
382m
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$381.5m
Earnings US$26.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
21.68%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.93%
Calculation
US$26.85m
Earnings '28
x
94.35x
PE Ratio '28
=
US$2.53b
Market Cap '28
US$2.53b
Market Cap '28
/
32.28m
No. shares '28
=
US$78.48
Share Price '28
US$78.48
Share Price '28
Discounted to 2025 @ 13.00% p.a.
=
US$54.39
Fair Value '25